PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia

Cancer Biology and Therapy

Volumn 14, Issue 6, 2013, Pages 546-555

  Barboza, Nora ^a   Minakhina, Svetlana ^b   Medina, Daniel J ^a   Balsara, Binaifer ^c   Greenwood, Sonya ^a   Huzzy, Lien ^a   Rabson, Arnold B ^d   Steward, Ruth ^b   Schaar, Dale G ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Acute lymphoblastic leukemia; Acute myelogenous leukemia; Cellular proliferation; Hematopoietic stem cells; PDCD2

Indexed keywords

A 549; PDCD 2 PROTEIN; PROTEIN; RNA; UNCLASSIFIED DRUG; VIRUS VECTOR; APOPTOSIS REGULATORY PROTEIN; MESSENGER RNA; PDCD2 PROTEIN, HUMAN; TUMOR MARKER;

ACUTE LEUKEMIA; ARTICLE; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; NUCLEOTIDE SEQUENCE; PREDICTION; PREDICTOR VARIABLE; ACUTE GRANULOCYTIC LEUKEMIA; CELL PROLIFERATION; GENE EXPRESSION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PATHOLOGY; PROSPECTIVE STUDY; TUMOR CELL LINE; TUMOR RECURRENCE;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84879179912     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.24484     Document Type: Article

References (26)

1. Owens GP, Hahn WE, Cohen JJ. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 1991; 11:4177-88; PMID:2072913.
2. Minakhina S, Druzhinina M, Steward R. Zfrp8, the Drosophila ortholog of PDCD2, functions in lymph gland development and controls cell proliferation. Development 2007; 134:2387-96; PMID:17522156; http://dx.doi.org/10.1242/dev. 003616.
3. Chen Q, Qian K, Yan C. Cloning of cDNAs with PDCD2(C) domain and their expressions during apoptosis of HEK293T cells. Mol Cell Biochem 2005; 280:185-91; PMID:16311922; http://dx.doi.org/10.1007/s11010-005-8910-z.
4. D'Mello SR, Galli C, Ciotti T, Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A 1993; 90:10989-93; PMID:8248201; http://dx.doi.org/10.1073/pnas.90.23.10989.
5. Guénal I, Mignotte B. Studies of specific gene induction during apoptosis of cell lines conditionally immortalized by SV40. FEBS Lett 1995; 374:384-6; PMID:7589576; http://dx.doi.org/10.1016/0014-5793(95)01157-A.
6. Vaux DL, Häcker G. Cloning of mouse RP-8 cDNA and its expression during apoptosis of lymphoid and myeloid cells. DNA Cell Biol 1995; 14:189-93; PMID:7880439; http://dx.doi.org/10.1089/dna.1995.14.189.
7. Minakhina S, Steward R. Hematopoietic stem cells in Drosophila. Development 2010; 137:27-31; PMID:20023157; http://dx.doi.org/10.1242/dev. 043943.
8. Kramer J, Granier CJ, Davis S, Piso K, Hand J, Rabson AB, et al. PDCD2 Controls Hematopoietic Stem Cell Differentiation During Development. Stem Cells Dev 2012; 22:58-72; PMID:22800338.
9. Kokorina NA, Granier CJ, Zakharkin SO, Davis S, Rabson AB, Sabaawy HE. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells. Exp Hematol 2012; 40:1028-42, e3; PMID:22922207; http://dx.doi.org/10.1016/j.exphem.2012.08.004.
10. Mu W, Munroe RJ, Barker AK, Schimenti JC. PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Dev Biol 2010; 347:279-88; PMID:20813103; http://dx.doi.org/10.1016/j.ydbio.2010.08.026.
11. Amiel A, Mulchanov I, Elis A, Gaber E, Manor Y, Fejgin M, et al. Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet 1999; 112:53-6; PMID:10432937; http://dx.doi.org/10.1016/S0165-4608(98)00255-6.
12. Kawakami T, Furukawa Y, Sudo K, Saito H, Takami S, Takahashi E, et al. Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death. Cytogenet Cell Genet 1995; 71:41-3; PMID:7606924; http://dx.doi.org/10.1159/000134058.
13. Stilgenbauer S, Bullinger L, Benner A, Wildenberger K, Bentz M, Döhner K, et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999; 13:1331-4; PMID:10482982; http://dx.doi.org/10.1038/sj.leu.2401499.
14. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 2002; 99:2860-5; PMID:11854457; http://dx.doi.org/10.1073/pnas. 042702599.
15. Baron BW, Zeleznik-Le N, Baron MJ, Theisler C, Huo D, Krasowski MD, et al. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proc Natl Acad Sci U S A 2007; 104:7449-54; PMID:17468402; http://dx.doi.org/10.1073/pnas.0701770104.
16. Steinemann D, Gesk S, Zhang Y, Harder L, Pilarsky C, Hinzmann B, et al. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms. Genes Chromosomes Cancer 2003; 37:421-6; PMID:12800155; http://dx.doi.org/10.1002/gcc. 10231.
17. Scarr RB, Sharp PA. PDCD2 is a negative regulator of HCF-1 (C1). Oncogene 2002; 21:5245-54; PMID:12149646; http://dx.doi.org/10.1038/sj.onc.1205647.
18. Goto H, Motomura S, Wilson AC, Freiman RN, Nakabeppu Y, Fukushima K, et al. A single-point mutation in HCF causes temperature-sensitive cellcycle arrest and disrupts VP16 function. Genes Dev 1997; 11:726-37; PMID:9087427; http://dx.doi.org/10.1101/gad.11.6.726.
19. Julien E, Herr W. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1. EMBO J 2003; 22:2360-9; PMID:12743030; http://dx.doi.org/10.1093/emboj/cdg242.
20. Tyagi S, Chabes AL, Wysocka J, Herr W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol Cell 2007; 27:107-19; PMID:17612494; http://dx.doi.org/10.1016/j.molcel.2007.05.030.
21. Fukae J, Sato S, Shiba K, Sato K, Mori H, Sharp PA, et al. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease. FEBS Lett 2009; 583:521-5; PMID:19146857; http://dx.doi.org/10.1016/j.febslet.2008.12.055.
22. Misaghi S, Ottosen S, Izrael-Tomasevic A, Arnott D, Lamkanfi M, Lee J, et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol 2009; 29:2181-92; PMID:19188440; http://dx.doi.org/10.1128/MCB.01517-08.
23. Collins RH Jr. CD34+ selected cells in clinical transplantation. Stem Cells 1994; 12:577-85; PMID:7533577; http://dx.doi.org/10.1002/stem.5530120605.
24. Mayani H. Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res 2011; 42:645-51; PMID:22154618; http://dx.doi.org/10.1016/j.arcmed.2011.11.010.
25. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993; 90:8392-6; PMID:7690960; http://dx.doi.org/10.1073/pnas.90.18.8392.
26. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8; PMID:18546601; http://dx.doi.org/10. 1038/nprot.2008.73.